Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “mTOR”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT01420081
What this trial is testing

Two Dual PI3K/mTOR Inhibitors, PF-04691502 And PF-05212384 In Patients With Recurrent Endometrial Cancer

Who this might be right for
Endometrial Neoplasms
Pfizer 67
Early research (Phase 1)Study completedNCT00574366
What this trial is testing

Erlotinib and Everolimus in Treating Patients With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Vanderbilt-Ingram Cancer Center 14
Large-scale testing (Phase 3)UnknownNCT02055079
What this trial is testing

Pulsed Oral Sirolimus in Autosomal Dominant Polycystic Kidney Disease

Who this might be right for
Polycystic Kidney, Type 1 Autosomal Dominant DiseasePolycystic Kidney, Type 2 Autosomal Dominant Disease
Medical University of Vienna 68
Large-scale testing (Phase 3)Study completedNCT00355862
What this trial is testing

Immunosuppression in Patients Undergoing Liver Transplantation for Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
University of Regensburg 525
Early research (Phase 1)Not Yet RecruitingNCT07667413
What this trial is testing

Topical TOR-582 Treatment of Epistaxis in HHT

Who this might be right for
Hereditary Hemorrhagic Telangiectasia (HHT)Epistaxis
Columbia University 27
Testing effectiveness (Phase 2)Active Not RecruitingNCT03047213
What this trial is testing

Sapanisertib in Treating Patients With Locally Advanced or Metastatic Bladder Cancer With TSC1 and/or TSC2 Mutations

Who this might be right for
Locally Advanced Bladder Urothelial CarcinomaMetastatic Transitional Cell CarcinomaMetastatic Urothelial Carcinoma+3 more
National Cancer Institute (NCI) 17
Testing effectiveness (Phase 2)Study completedNCT05567068
What this trial is testing

Atorvastatin Efficacy and Safety in Patients With Ulcerative Colitis

Who this might be right for
Inflammatory Bowel Diseases
Tanta University 54
Testing effectiveness (Phase 2)Study completedNCT00086125
What this trial is testing

Study of AP23573 in Patients With Relapsed or Refractory Hematologic Malignancies (8669-024)(COMPLETED)

Who this might be right for
Hematologic MalignanciesLeukemiaMyelodysplastic Syndromes+2 more
Merck Sharp & Dohme LLC 57
Large-scale testing (Phase 3)Study completedNCT05495425
What this trial is testing

Clinical Study of NPC-12Y Gel in Patients With Skin Lesions Associated With TSC

Who this might be right for
Tuberous Sclerosis Complex
Nobelpharma 43
Testing effectiveness (Phase 2)Study completedNCT01177397
What this trial is testing

Study to Assess Safety, Pharmacokinetics, and Efficacy of Oral CC-223 for Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma or Multiple Myeloma

Who this might be right for
Multiple MyelomaDiffuse Large B-Cell LymphomaGlioblastoma Multiforme+4 more
Celgene 226
Testing effectiveness (Phase 2)Active Not RecruitingNCT04584710
What this trial is testing

RTB101 as COVID-19 Post-Exposure Prophylaxis in Older Adults

Who this might be right for
Covid19
Restorbio Inc. 60
Not applicableLooking for participantsNCT06504225
What this trial is testing

EVEROLD LONG TERM FOLLOW-UP

Who this might be right for
Transplant; Complication, Failure
University Hospital, Brest 260
Large-scale testing (Phase 3)Study completedNCT00863655
What this trial is testing

Everolimus in Combination With Exemestane in the Treatment of Postmenopausal Women With Estrogen Receptor Positive Locally Advanced or Metastatic Breast Cancer Who Are Refractory to Letrozole or Anastrozole

Who this might be right for
Breast Cancer
Novartis Pharmaceuticals 724
Early research (Phase 1)Study completedNCT01390818
What this trial is testing

Trial of MEK Inhibitor and PI3K/mTOR Inhibitor in Subjects With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Locally Advanced Solid TumorMetastatic Solid TumorBreast Cancer+3 more
EMD Serono 146
Early research (Phase 1)Study completedNCT01857193
What this trial is testing

Phase Ib Trial of LEE011 With Everolimus (RAD001) and Exemestane in the Treatment of Hormone Receptor Positive HER2 Negative Advanced Breast Cancer

Who this might be right for
Breast Cancer
Novartis Pharmaceuticals 132
Testing effectiveness (Phase 2)Looking for participantsNCT05104983
What this trial is testing

Stopping TSC Onset and Progression 2B: Sirolimus TSC Epilepsy Prevention Study

Who this might be right for
Tuberous Sclerosis ComplexEpilepsy
Darcy Krueger 64
Testing effectiveness (Phase 2)Study completedNCT01090466
What this trial is testing

Gemcitabine Hydrochloride, Cisplatin, and Temsirolimus as First-Line Therapy in Treating Patients With Locally Advanced and/or Metastatic Transitional Cell Cancer of the Urothelium

Who this might be right for
Bladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterUrethral Cancer
Cardiff University 15
Testing effectiveness (Phase 2)Ended earlyNCT02504892
What this trial is testing

Everolimus Therapy in People With Birt-Hogg-Dube Syndrome (BHD)-Associated Kidney Cancer or Sporadic Chromophobe Renal Cancer

Who this might be right for
Renal CancerBirt-Hogg-Dube Syndrome
National Cancer Institute (NCI) 3
Early research (Phase 1)Ended earlyNCT01347866
What this trial is testing

Clinical Study Of PI3K/mTOR Inhibitors In Combination With An Oral MEK Inhibitor Or Irinotecan In Patients With Advanced Cancer

Who this might be right for
Advanced Cancer
Pfizer 105
Testing effectiveness (Phase 2)UnknownNCT00490789
What this trial is testing

Trial of Efficacy and Safety of Sirolimus in Tuberous Sclerosis and LAM

Who this might be right for
Tuberous SclerosisLymphangioleiomyomatosis
Cardiff University 14
Next Page